Week 5: Guidelines for Acute Stroke, part 3

Continuing with the stroke guidelines…earlier posts here and here.

Section 3: Endovascular interventions through antiplatelet agents

  • Intra-arterial tPA is actually not well studied. The evidence for intra-arterial thrombolysis is a couple trials with urokinase.
  • Both the Solitaire and the Trevo, stent retrieval devices, outperformed Merci in head-to-head trials
  • Immediate anticoagulation (like for NSTEMIs) hasn’t shown any net benefit
  • Even the evidence of immediate aspirin is kind of weak: two trials individually had a non-significant effect on death/disability when started within 48 hours, but when combined, there was a modest effect, likely attributable to a reduction of early recurrent stroke
  • Plavix takes at least 5 days for full effect when started at 75mg daily
  • Aspirin comes in an IV formulation! But adding it to tPA worsened outcomes.
Advertisements

2 Comments

Filed under Articles

2 responses to “Week 5: Guidelines for Acute Stroke, part 3

  1. Pingback: Week 5: Acute Stroke Guidelines, part 4 | Evidenced

  2. Pingback: Week 6: Management of Acute Stroke, part 1 | Evidenced

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s